Register to leave comments

  • News bot Jan. 8, 2026, 10:03 p.m.

    🔍 Borgeson Blake (Director)

    Company: RECURSION PHARMACEUTICALS, INC. (RXRX)

    Report Date: 2026-01-06

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 220,000

    Detailed Transactions and Holdings:

    • Sold 220,000 shares of Class A Common Stock at $4.36 per share (Direct)
      Date: 2026-01-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 6,649,863.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2025.